Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Japan
  4. Japan Exchange
  5. Chugai Pharmaceutical Co., Ltd
  6. Company
    4519   JP3519400000

CHUGAI PHARMACEUTICAL CO., LTD

(4519)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Chugai Pharmaceutical Co., Ltd
CHUGAI PHARMACEUTICAL CO., LTD. is a Japan-based company mainly engaged in the research, development, manufacture, sale, import and export of pharmaceutical products. The pharmaceutical products and medical devices for patients include ACTEMRA, Avastin, ALAGLIO, Aresensa, Kadosaira, Gazaiba, Seruseputo, Zeruborafu, Zeroda, Taruseba, Tecentoriku, Pajeta and other products. The products are mainly applied to the treatment of cancer, kidney diseases, kidney transplantation, bone and joint diseases such as rheumatoid arthritis, osteoporosis, knee osteoarthritis and locomotive syndrome, influenza, hemophilia and other diseases. The Company is also engaged in the provision of management services, transportation and storage services, as well as drug information literature research services. The Company operates within the domestic market and to overseas markets, including Switzerland, United Kingdom, Germany, France, China, Singapore, Korea and the United States.

Number of employees : 7 555 people.
Sales per Business
20192020Delta
Pharmaceuticals588 896.0085.8%633 314.0080.5% +7.54%
Royalties and Other97 288.0014.2%153 631.0019.5% +57.91%
JPY in Million
Sales per region
20192020Delta
Japan443 965.0064.7%418 958.0053.2% -5.63%
Switzerland222 061.0032.4%347 583.0044.2% +56.53%
Overseas20 158.002.9%20 405.002.6% +1.23%
JPY in Million
Managers
Name Title Age Since
Tatsuro Kosaka Manager-Pharmaceutical Business Strategy Office 68 2000
Osamu Okuda Manager-Life Cycle Management II 58 2008
Itagaki Toshiaki CFO, Manager-Information Technology & Accounting - 2018
Hisafumi Okabe Senior Executive Officer & Head-Research - 2018
Junichi Nezu Executive Officer, GM-Research & Development - -
Masayuki Oku Independent Outside Director 77 2015
Yoichiro Ichimaru Independent Outside Director 73 2017
Mariko Momoi Independent Outside Director 73 2020
Yoko Kitagawa Group Manager-Finance & Accounting - -
Shinji Hidaka Executive Officer & General Manager-Sales - -
Members of the board
Name Title Age Since
Tatsuro Kosaka Manager-Pharmaceutical Business Strategy Office 68 2000
Motoo Ueno Managing Director 64 1997
Masayuki Oku Independent Outside Director 77 2015
Yoichiro Ichimaru Independent Outside Director 73 2017
Christoph Franz Director 61 2017
William N. Anderson Director 55 2019
James H. Sabry, Dr. Director 63 2019
Osamu Okuda Manager-Life Cycle Management II 58 2008
Mariko Momoi Independent Outside Director 73 2020
Shareholders
NameEquities%
Roche Holding AG 1,005,670,000 59.9%
Nomura Asset Management Co., Ltd. 52,561,294 3.13%
Chugai Pharmaceutical Co., Ltd. 34,848,900 2.08%
William Blair Investment Management LLC 26,811,000 1.60%
Nikko Asset Management Co., Ltd. 25,321,195 1.51%
Daiwa Asset Management Co. Ltd. 24,581,097 1.46%
The Vanguard Group, Inc. 17,236,612 1.03%
Mitsubishi UFJ Kokusai Asset Management Co., Ltd. 13,078,487 0.78%
Wellington Management Co. LLP 11,560,899 0.69%
Norges Bank Investment Management 9,642,679 0.57%
Holdings
NameEquities%Valuation
CHUGAI PHARMACEUTICAL CO., LTD (4519) 34,848,900 2.08% 1,130,308,041 USD
ONCOLYS BIOPHARMA INC. (4588) 456,600 2.62% 2,093,566 USD
Markets and indexes
- First Section
- Nikkei 225 /
Stock Exchange Codes
- Bloomberg Code :  4519:JP
- Reuters Code :  4519.T
- Datastream Code :  
Company contact information
Chugai Pharmaceutical Co., Ltd
Nihonbashi Mitsui Tower 1-1 Nihonbashi-Muromachi 2-chome
JP-103-8324 Chuo-ku, Tokyo

Phone : +81 3 3281 6611
Fax : +81 3 3281 6607
web site : https://www.chugai-pharm.co.jp/english/ir
Brand Portfolio
In partnership withAllbrands.markets
More brands of Chugai Pharmaceutical Co., Ltd
Sector Other Pharmaceuticals
1st jan.Capi. (M$)
CHUGAI PHARMACEUTICAL CO., LTD-1.47%53 179
JOHNSON & JOHNSON-3.40%434 036
ROCHE HOLDING AG-4.87%319 830
PFIZER, INC.-10.60%296 303
ABBVIE INC.-2.53%233 325
ELI LILLY AND COMPANY-11.98%220 356
NOVO NORDISK A/S-14.11%219 146
MERCK & CO., INC.4.36%202 025
NOVARTIS AG-0.51%195 853
ASTRAZENECA PLC0.85%183 867
BRISTOL-MYERS SQUIBB COMPANY3.58%141 036
SANOFI2.66%129 475
AMGEN INC.1.22%128 267
GLAXOSMITHKLINE PLC2.53%112 384
BAYER AG9.83%57 517
TAKEDA PHARMACEUTICAL COMPANY LIMITED5.93%45 488
JIANGSU HENGRUI MEDICINE CO., LTD.-11.38%45 167
DAIICHI SANKYO CO., LTD.-10.80%43 949
ASTELLAS PHARMA INC.3.37%31 486
YUNNAN BAIYAO GROUP CO.,LTD-6.82%19 730
HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY-19.80%19 602